OKYO Pharma Limited Accounts Payable

OKYO Pharma Limited (OKYO) currently reports a accounts payable of $7.1M as of March 2026. That compares with $7.9M in the prior-year period — down 9.7% year over year. Use the charts on this page to explore OKYO Pharma Limited's accounts payable history and peer comparisons.

OKYO Pharma Limited's accounts payable decreased from $7.9M to $7.1M — a 9.7% year-over-year decrease (period ending March 2026). Watching multi-year history on the chart below helps separate one-off swings from a lasting trend.

OKYO Pharma Limited reported $7.1M in accounts payable as of March 2026. That compares with $7.9M in the prior-year period — down 9.7% year over year. Absolute dollar amounts are most useful when compared with prior periods, peers, and related line items such as revenue, assets, or liabilities on Stockcircle.

Start with the current accounts payable of $7.1M, then check the historical chart for trend and the peer comparison chart for relative positioning. From there, open related valuation or income-statement pages for OKYO Pharma Limited, and consider following OKYO for alerts when major investors trade the stock.

OKYO Pharma Limited is classified in the Healthcare sector. On accounts payable, it currently shows $7.1M. Sector peers often share similar capital intensity and growth regimes, so relative rankings inside Healthcare are usually more informative than comparing OKYO with unrelated industries.